banda transcan 2 2016ul


ERA-NET TRANSCAN-3

The consortium of the new project: TRANSCAN-3 Sustained collaboration of national and regional programmes in cancer research, funded by the European Commission under Horizon 2020 from 2021 to 2026 (Grant Agreement no. 964264),

has launched its first Joint Transnational Call co-funded by the European Commission (JTC 2021)

on the topic:

"Next generation cancer immunotherapy: targeting the tumour microenvironment"

28 funding organizations from 19 countries are participating.

The submission deadline for pre-proposals is on 29thof June 2021.
It is expected that consortia invited for the full-proposal stage will be asked to submit their proposal on November 2021.

go to the call web page


ERA-NET TRANSCAN-2

The ERA-NET: Aligning national/regional translational cancer research programmes and activities - TRANSCAN-2 is a project funded by the European Commission under the EU framework programme Horizon2020 (Grant Agreement no. 643638) from 2015 to 2021.

It is the continuation of the previous ERA-NET on translational cancer research TRANSCAN, funded under the FP7 from 2011 to 2014.

TRANSCAN-2 is a collaborative network of ministries, funding agencies and research councils with programmes in translational cancer research. The network is composed of 31 partners from 19 Countries.

 Coordination:
The project is coordinated by the Ministry of Health, Italy
Coordinator: Dr. Giovanni Leonardi. Deputy coordinator: Dr. Gaetano Guglielmi


Contact:
Dr. Silvia Paradisi
Project Manager
Italian National Institute of Health
Viale Regina Elena, 299
00161 Rome, Italy
 
mail to: This email address is being protected from spambots. You need JavaScript enabled to view it.

The TRANSCAN-2 project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 643638. The content of this website is the sole responsibility of the project partners and in no way represents the view of the European Commission or its services. Warranties and Liability While every effort is made to ensure that the content of this website is accurate, the website is provided “as is” and the TRANSCAN-2 partnership makes no representations or warranties in relation to the accuracy or completeness of the information on this website. All of the material published on this website is for information purposes only. The information on this website is current at the date of publication but may be subject to change. We take no responsibility and will not be held liable for errors, omissions in, delays or interruptions to or cessation of access to this website, through negligence or for any other reason whatsoever. We do not guarantee that this website or third party websites will be free from viruses. Nothing on this website should be taken to constitute professional advice or a formal recommendation and we exclude all representations and warranties relating to the content and use of this site. Links to other websites are provided for information purposes only. We are unable to provide any guarantee regarding the accuracy or completeness of the content of such sites, or the reliability, quality or effectiveness of any products provided through external websites. A link to an external site does not imply an endorsement of the views, information or products provided or held by such websites. The TRANSCAN-2 partnership hereby excludes all liability for any claims, loss, demands or damages of any kind whatsoever howsoever arising as a result of accessing third party websites from the links contained in this website.
Contacts
Any comments or queries should be directed to This email address is being protected from spambots. You need JavaScript enabled to view it.

This website is maintained at the Istituto Superiore di Sanità, ISS, (Italian National Institute of Health), located in Viale Regina Elena 299, 00161, Rome, Italy.
 
Please refer to the ISS Privacy Policy
 
 
Page 3 of 3

TRANSCAN News

Launch of the call: JTC 2021
The new TRANSCAN-3 project consortium is launching the first Joint Transnational Call for proposals, co-funded by the European Commission, on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment"

International Networking Event (virtual)
on 22 April 2021 hrs 9:00 CET
will focus on the forthcoming co-funded JTC 2021 on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment" 
the event is organized by TUBITAK under the “Turkey in Horizon 2020 Phase II” Technical Assistance Project
in cooperation with TRANSCAN-3

ERA-NET Cofund TRANSCAN-3:
 Sustained collaboration of national and regional programmes in cancer research
is the new project funded by the European Commission under H2020  which started on 1st March 2021 and will last five years (G. A. no. 964264)

A TRANSCAN-2 brochure, highlighting key achievements, is available for download

 

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.

Who's Online

We have 17 guests and no members online